A6RI 
GENETICS 
14142 DENVER WEST PARKWAY 
DENVER, COLORADO 80401 
CORPORATION 
303-g 77 '- 0 8 0 e- 
April 1, 1983 
Director, Office of Recombinant 
DNA Activities 
Building 31, Room 3B10 
National Institute of Health 
Bethesda, MD 20205 
Dear Sir: 
The enclosed comment is submitted by Agri genetics Corporation for consid- 
eration at the April 11 meeting of the Committee. The agenda items to 
which our conment is directed are enumerated in accordance with the announce- 
ment published in the Federal Register, March 4, 1983. 
Sincerely yours. 
Lorance L. Greenlee, Ph.D., J.D 
Vice President 
LLG/alr 
Enel osure 
[ 616 ] 
